Upstate Research Spotlight
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
There are currently no approved human vaccines for Lyme disease, and PF-07307405 is the Lyme disease vaccine candidate which has currently advanced the furthest along the clinical more »
Upstate first in New York outside NYC to offer advanced atrial fibrillation ablation technology
Upstate Medical University is now offering a new technology for atrial fibrillation ablationsand is the only hospital in New York state outside of New York City to offer it. more »
Interview: Dr. Stephen Thomas, Upstate Global Health Institute Director, on the latest on vaccines and contagion
Support the Institute
Our faculty and students are working hard to find solutions to many global health problems. You can finance a student's trip abroad to gain hands-on experience in the field, fund local community-based research and outreach projects, support service-learning opportunities, and more. Any amount can help, so please consider a gift.
